Myxomas of the larynx are very uncommon. The reported sites of involvement are the vocal cords, the aryepiglottic fold, and the epiglottis. They are more common in the vocal cords. As far as we are aware, only ten cases of vocal cord myxomas have been previously reported. We describe herein a case of the cellular variant of myxoma in the right vocal cord and review the literature. To the best of our knowledge, a cellular myxoma (CM) in a vocal cord has not been previously reported.
The patient underwent phonosurgery under general anesthesia.
The specimen consisted of a glistening white, gelatinous, polypoid mass measuring 0.9 x 0.6 x 0.3 cm. Histopathological examination revealed an excrescent tissue fragment consisting of squamous mucosa that was partially atrophic and a mesenchymal neoplasm (Figure 1A). The tumor showed spindled and stellate cells suspended in a background of loose myxoid matrix. Cell density was variable throughout the tumor with hypercellular (Figure 1B) and hypocellular areas (Figure 1C). Hypercellular areas occupied about 90% of the tumor. In these areas, there were more numerous blood vessels and collagen fibers (Figure 1D). In addition, occasional thick-walled vessels with smooth muscle in their walls were present (Figure 2A). Tumor cells were uniform and bland in appearance (Figure 2B). They showed small hyperchromatic nuclei with scant tapering eosinophilic cytoplasm (Figure 2C). Scattered muciphages were also observed. Fluid-filled microcystic spaces were seen occasionally. Cellular pleomorphism, multinucleated giant cells, mitoses, or necrosis were not present. The myxoid matrix stained positive with Alcian blue at pH 2.5 (Figure 2D). Immunohistochemical study revealed diffuse positivity for vimentin (Figure 3A) and focal positivity for CD34 (Figure 3B) in the constituent cells. These cells were not reactive for S100 protein, neurofilament protein, epithelial membrane antigen, claudin-1, GLUT- 1, smooth muscle actin and MUC4. Ki-67 labeled only a few nuclei of the squamous epithelium. The deep surgical border was very close to the tumor boundary.
The patient was discharged in hours. One month later his voice was much improved. No signs of recurrence were observed.
Table I: Vocal cord myxomas reported in literature
Cells of a myxoma originate from modified fibroblastic cells that lack the ability to polymerize collagen. As an alternative, they produce an excessive amount of glycosaminoglycans giving them a gelatinous appearance on gross examination. The process suggests an underlying localized error in tissue metabolism [13].
CM is characterized by hypercellular areas that occupy from 10 to 90% of the tumor. These foci have increased number of cells, more prominent vascularity, increased collagen content and less extracellular myxoid matrix than classic myxoma. The hypercellular regions are not associated with cytologic atypia, multinucleated giant cells, mitotic activity, or necrosis. Vessels are capillary-sized but occasional thickwalled vessels with smooth muscle in their walls can be present. CMs usually show sparse paucicellular areas of classic myxoma with scant capillary-sized vessels [1,2].
All the cases of CM reported out of the larynx have behaved in a benign fashion with only a small risk of local nondestructive recurrence if not excised completely [1,2]. Thus, in general, simple complete local excision is the adequate treatment.
The main differential diagnosis includes myxoid neurofibroma, low-grade myxofibrosarcoma, low-grade fibromyxoid sarcoma, and myxoid liposarcoma. Myxoid neurofibroma shows spindled elongated cells with tapering, wavy or bent nuclei and pale indistinct cytoplasms embedded in abundant myxoid background. Intralesional neural fibers are demonstrated with neurofilament protein. Besides, a considerable number of cells are positive for S100 protein [14,15]. CM, unlike low-grade myxofibrosarcoma, does not show any cytonuclear atypia and does not have the classical curvilinear vascular architecture, often with a perivascular increase of cellularity [16]. Low-grade fibromyxoid sarcoma is diffusely more cellular and is characterized by alternating myxoid and collagenous zones containing bland spindle cells with a whorled growth pattern. It may show areas of hyalinizing spindle cells with giant rosettes. MUC4 immunostaining has been found to be highly sensitive and specific for the diagnosis [17]. Myxoid liposarcoma has small, bland spindle-shaped or more rounded cells, lipoblasts and a typically delicate plexiform or branching chicken-wire capillary vasculature [18].
In conclusion, CM of the vocal cord is a benign mesenchymal tumor that shows foci of increased cellularity and vascularity, with presence of thick-walled vessels, and increased collagen content. The recognition of this tumor is important to avoid a misdiagnosis of any type of lowgrade myxoid sarcoma. Although very rare, CM should be considered in the differential diagnosis of any vocal cord mass to allow for adequate treatment. Surgery is considered curative.
1) Nielsen GP, O´Connell JX, Rosenberg AE. Intramuscular
myxoma. A clinicopathologic study of 51 cases with emphasis
on hypercellular and hypervascular variants. Am J Surg Pathol.
1998;22:1222-7.
2) van Roggen JFG, McMenamin ME, Fletcher CDM. Cellular
myxoma of soft tissue: A clinicopathological study of 38 cases
confirming indolent clinical behaviour. Histopathology.
2001;39:287-97.
3) Hadley J, Gardiner Q, Dilkes M, Boyle M. Myxoma of the larynx:
A case report and review of the literature. J Laryngol Otol.
1994;108:811-2.
4) Tsunoda K, Nosaka K, Housui M, Murano E, Ishikawa M,
Imamura Y. A rare case of laryngeal myxoma. J Laryngol Otol.
1997;111:271-3.
5) Kim KM, Kim SC, Jeong HJ, Kie JH. Myxoma: Life-threatening
benign nonepithelial tumor of the larynx. Yonsey Med J.
1997;38:187-9.
6) Orliaguet O, Pépin JL, Veale D, Kelkel E, Pinel L, Lévy P.
Hunter´s syndrome and associated sleep apnea cured by CPAP
and surgery. Eur Respir J. 1999;13:1195-7.
7) Idrees MT, Hessler R, Terris D, Mixson C, Wang BY. Unusual
polypoid laryngeal myxoma. Mt Sinai J Med. 2005;72:282-4.
8) Nakamura A, Iguchi H, Kusuki M, Yamane H, Matsuda M,
Osako S. Laryngeal myxoma. Acta Otolaryngol. 2008;128:110-2.
9) Ali S, MacDougall G, Wallace W. Myxoma-rare laryngeal
presentation. Internet J Otorhinolaryngol. 2008;11:1-4.
10) Song YS, Jang S-H, Min KW, Na W, Jang SM, Jun YJ, Paik SS.
Myxoma of the larynx presenting as a nodule. Korean J Pathol.
2008;42:306-7.
11) Singh B, Uddesh SK. Laryngeal myxoma: Emergency
management. Natl J Med Res. 2014;4:175-7.
12) Ritchie A, Youngerman J, Fantasia JE, Kahn L, Cocker RS.
Laryngeal myxoma: A case report and review of the literature.
Head Neck Pathol. 2014;8:204-8.
13) Weiss SW, Goldblum JR. Enzinger and Weiss´s soft tissue
tumors. 4th ed. St. Louis, Missouri: Mosby Inc; 2001.
14) Liu J, Wong CF, Lim F, Kanagalingam J. Glottic neurofibroma in
an elderly patient: A case report. J Voice. 2013;27:644-6.
15) Mevio E, Galioto P, Scelsi M, Re P. Neurofibroma of vocal cord:
Case report. Acta Otorhinolaryngol Belg. 1990;44:447-50.
16) Nishimura G, Sano D, Hanashi M, Yamanaka S, Tanigaki Y,
Taguchi T, Horiuchi C, Matsuda H, Mikami Y, Tsukuda M.
Myxofibrosarcoma of the hypopharynx. Auris Nasus Larynx.
2006;33:93-6.